Annual Accounts Receivable
$298.00 K
-$186.00 K-38.43%
31 December 2023
Summary:
Aclaris Therapeutics annual accounts receivable is currently $298.00 thousand, with the most recent change of -$186.00 thousand (-38.43%) on 31 December 2023. During the last 3 years, it has fallen by -$474.00 thousand (-61.40%). ACRS annual accounts receivable is now -61.40% below its all-time high of $772.00 thousand, reached on 31 December 2020.ACRS Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$343.00 K
+$18.00 K+5.54%
30 September 2024
Summary:
Aclaris Therapeutics quarterly accounts receivable is currently $343.00 thousand, with the most recent change of +$18.00 thousand (+5.54%) on 30 September 2024. Over the past year, it has dropped by -$3000.00 (-0.87%). ACRS quarterly accounts receivable is now -98.23% below its all-time high of $19.37 million, reached on 30 June 2019.ACRS Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRS Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.4% | -0.9% |
| 3 y3 years | -61.4% | -57.7% |
| 5 y5 years | -47.1% | -49.0% |
ACRS Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -61.4% | at low | -57.7% | +15.1% |
| 5 y | 5 years | -61.4% | at low | -63.5% | +15.1% |
| alltime | all time | -61.4% | -98.2% |
Aclaris Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $343.00 K(+5.5%) |
| June 2024 | - | $325.00 K(-12.9%) |
| Mar 2024 | - | $373.00 K(+25.2%) |
| Dec 2023 | $298.00 K(-38.4%) | $298.00 K(-13.9%) |
| Sept 2023 | - | $346.00 K(-19.7%) |
| June 2023 | - | $431.00 K(-37.2%) |
| Mar 2023 | - | $686.00 K(+41.7%) |
| Dec 2022 | $484.00 K(-22.3%) | $484.00 K(-18.9%) |
| Sept 2022 | - | $597.00 K(-6.3%) |
| June 2022 | - | $637.00 K(+0.6%) |
| Mar 2022 | - | $633.00 K(+1.6%) |
| Dec 2021 | $623.00 K(-19.3%) | $623.00 K(-23.2%) |
| Sept 2021 | - | $811.00 K(-13.6%) |
| June 2021 | - | $939.00 K(+14.9%) |
| Mar 2021 | - | $817.00 K(+5.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $772.00 K(+9.7%) | $772.00 K(-13.0%) |
| Sept 2020 | - | $887.00 K(+14.5%) |
| June 2020 | - | $775.00 K(-16.9%) |
| Mar 2020 | - | $933.00 K(+32.5%) |
| Dec 2019 | $704.00 K(+25.0%) | $704.00 K(+4.6%) |
| Sept 2019 | - | $673.00 K(-96.5%) |
| June 2019 | - | $19.37 M(+22.5%) |
| Mar 2019 | - | $15.82 M(+2709.4%) |
| Dec 2018 | $563.00 K(+17.0%) | $563.00 K(-45.5%) |
| Sept 2018 | - | $1.03 M(-52.7%) |
| June 2018 | - | $2.18 M(+312.5%) |
| Mar 2018 | - | $529.00 K(+10.0%) |
| Dec 2017 | $481.00 K(>+9900.0%) | $481.00 K(-26.9%) |
| Sept 2017 | - | $658.00 K(>+9900.0%) |
| Dec 2016 | $0.00 | $0.00 |
FAQ
- What is Aclaris Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual accounts receivable year-on-year change?
- What is Aclaris Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly accounts receivable year-on-year change?
What is Aclaris Therapeutics annual accounts receivable?
The current annual accounts receivable of ACRS is $298.00 K
What is the all time high annual accounts receivable for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual accounts receivable is $772.00 K
What is Aclaris Therapeutics annual accounts receivable year-on-year change?
Over the past year, ACRS annual accounts receivable has changed by -$186.00 K (-38.43%)
What is Aclaris Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of ACRS is $343.00 K
What is the all time high quarterly accounts receivable for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly accounts receivable is $19.37 M
What is Aclaris Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, ACRS quarterly accounts receivable has changed by -$3000.00 (-0.87%)